نتائج البحث

Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).

• Authors : Lai YT; Division of Pulmonary Medicine, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.; Tsai YH

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology

• Source: Respiratory research [Respir Res] 2024 Oct 17; Vol. 25 (1), pp. 377. Date of Electronic Publication: 2024 Oct 17.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.

• Authors : Muro S; Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan. .; Kawayama T

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/blood

• Source: Respiratory research [Respir Res] 2024 Aug 05; Vol. 25 (1), pp. 297. Date of Electronic Publication: 2024 Aug 05.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Trends in initial pharmacological COPD treatment in primary care (2010-2021): a population-based study using the PHARMO Data Network.

• Authors : Rodrigues G; Lab3R, Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro (ESSUA), Edifício 30, Agras do Crasto, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal. .; iBiMED, Institute of Biomedicine, University of Aveiro, Edifício 30, Agras do Crasto, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal. .

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/epidemiology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis

• Source: Respiratory research [Respir Res] 2024 Dec 30; Vol. 25 (1), pp. 447. Date of Electronic Publication: 2024 Dec 30.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Expiratory flow limitation development index (ELDI): a novel method of assessing respiratory mechanics in COPD.

• Authors : Dean J; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK. .; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK. .

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy

• Source: Respiratory research [Respir Res] 2024 Oct 03; Vol. 25 (1), pp. 357. Date of Electronic Publication: 2024 Oct 03.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.

• Authors : Zhao N; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang west Road, Guangzhou Laboratory, Guangzhou, China.; Wu F

Subjects: Bronchodilator Agents* ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis; Humans

• Source: Respiratory research [Respir Res] 2022 Oct 31; Vol. 23 (1), pp. 298. Date of Electronic Publication: 2022 Oct 31.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial.

• Authors : Watz H; Velocity Clinical Research Grosshansdorf, Airway Research Center North (ARCN), Formerly Pulmonary Research Institute at Lung Clinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Wöhrendamm 80, 22927, Grosshansdorf, Germany. .; Kirsten AM

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Cross-Over Studies* ; Drug Combinations*

• Source: Respiratory research [Respir Res] 2024 Oct 17; Vol. 25 (1), pp. 378. Date of Electronic Publication: 2024 Oct 17.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.

• Authors : Usmani O; Asthma Lab, National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital, South Block, Royal Brompton Campus, Sydney St, Chelsea, London, SW3 6NP, UK. .; Roche N

Subjects: Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/administration & dosage ; Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/adverse effects ; Bronchodilator Agents*/Bronchodilator Agents*/Bronchodilator Agents*/administration & dosage

• Source: Respiratory research [Respir Res] 2021 Oct 07; Vol. 22 (1), pp. 261. Date of Electronic Publication: 2021 Oct 07.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.

• Authors : Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps-Universität Marburg, German Centre for Lung Research (DZL), Baldingerstraße, 35043, Marburg, Germany. .; Jones PW

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Benzyl Alcohols/Benzyl Alcohols/Benzyl Alcohols/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

• Source: Respiratory research [Respir Res] 2021 Oct 28; Vol. 22 (1), pp. 279. Date of Electronic Publication: 2021 Oct 28.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials.

• Authors : Kang, Jieun¹ (AUTHOR); Lee, Jae Seung² (AUTHOR); Lee, Sei Won² (AUTHOR)

• Source: Respiratory Research. 2/12/2021, Vol. 22 Issue 1, p1-11. 11p.

تفاصيل العنوان

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.

• Authors : Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, 08020, Barcelona, Spain. .; Astbury C

Subjects: Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/Adrenergic beta-2 Receptor Agonists/*administration & dosage ; Asthma/Asthma/Asthma/*drug therapy ; Bronchoconstriction/Bronchoconstriction/Bronchoconstriction/*drug effects

• Source: Respiratory research [Respir Res] 2020 Sep 09; Vol. 21 (Suppl 1), pp. 211. Date of Electronic Publication: 2020 Sep 09.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان